Koselugo 25 mg – DIN 02530147
Koselugo is Selumetinib Sulfate 25 mg (capsule), sold in Canada. It is used for neurofibromatosis 1. It is supplied by Alexion Pharma GmbH. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Selumetinib Sulfate 25 mg
- Brand
- Koselugo
- Strength
- 25 mg
- Used for
- Neurofibromatosis 1
- Form
- Capsule
- Manufacturer
- Alexion Pharma GmbH
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02530147
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Selumetinib used for?
Selumetinib is used for neurofibromatosis 1.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
KOSELUGO is indicated for the treatment of adult and pediatric patients 1 year of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).
From the FDA-approved label on DailyMed (published Jun 01, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02530147.
- It names Koselugo, Selumetinib Sulfate 25 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Koselugo by Alexion Pharma GmbH.
In Canada: prescription only.
Ingredients
Active: Selumetinib (Selumetinib Sulfate)